¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"maximum cell"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
Langerhans cell histiocytosis
¶û°Ô¸£Çѽº¼¼Æ÷Á¶Á÷±¸Áõ
large cell acanthoma
Å«¼¼Æ÷°¡½Ã¼¼Æ÷Á¾, ´ë¼¼Æ÷±Ø¼¼Æ÷Á¾
large cell carcinoma
´ë¼¼Æ÷¾ÏÁ¾, Å«¼¼Æ÷¾ÏÁ¾
lepra cell
³ªº´¼¼Æ÷
leukemic cell
¹éÇ÷º´¼¼Æ÷
Leydig cell tumor
¶óÀ̵ðÈ÷¼¼Æ÷Á¾¾ç
light cell
¹àÀº¼¼Æ÷
lipoid cell
ÁöÁú¼¼Æ÷
luteal cell
Ȳ(»ö)ü¼¼Æ÷
lymphoid cell
¸²ÇÁ°è¼¼Æ÷, ¸²ÇÁ¸ð¾ç¼¼Æ÷
lymphokine-activated killer cell
¸²Æ÷Ä«ÀÎȰ¼º»ìÇØ¼¼Æ÷
lymphopoietic cell
¸²ÇÁ±¸Çü¼º¼¼Æ÷
lymphosarcoma cell leukemia
¸²ÇÁÀ°Á¾¼¼Æ÷¹éÇ÷º´
lacunar cell
°ø°£¼¼Æ÷
mitotic cell
À¯»çºÐ¿±â¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
myoid cell
À¯»ç±ÙÀ°¼¼Æ÷
natural killer cell
ÀÚ¿¬¼¼Æ÷µ¶¼º¼¼Æ÷, ÀÚ¿¬¼¼Æ÷µ¶¼º¼¼Æ÷
nerve cell
½Å°æ¼¼Æ÷
neural crest cell
½Å°æ´É¼±¼¼Æ÷
neuroendocrine cell
½Å°æ³»ºÐºñ¼¼Æ÷
neuroepithelial cell
½Å°æ»óÇǼ¼Æ÷
neuroglial cell
½Å°æ¾Æ±³¼¼Æ÷
neurosecretory cell
½Å°æºÐºñ¼¼Æ÷
nevus cell
¸ð¹Ý¼¼Æ÷
nodal cell
°áÀý¼¼Æ÷
nucleated cell
À¯ÇÙ¼¼Æ÷
null cell
¹«Ç¥Áö¼¼Æ÷
nurse cell
(¢¡supporting cell) ¹öÆÀ¼¼Æ÷
oat cell carcinoma
±Í¸®¼¼Æ÷¾ÏÁ¾
osmiophilic cell
Ä£¿À½º¹Å¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
hybridoma, T cell
T¼¼Æ÷ ÇÏÀ̺긮µµ¸¶
hypercomplex cell
Ãʺ¹ÇÕ¼¼Æ÷(õ±ÜÜùêá¬øà)
hypersensitivity reactions,type ii(antibody-dependent cell-mediate cyt
IIÇü
hypersensitivity reactions,type iv(cell-mediated)
IVÇü
hypersensitivity, cell-mediated
¼¼Æ÷¸Å°³ °ú¹Î¹ÝÀÀ
hypersensitized cell
°ú°¨ÀÛ¼¼Æ÷.
hypoglycemia, beta cell tumor
ÀúÇ÷´ç(Áõ), º£Å¸¼¼Æ÷Á¾
hypoxic cell
Àú»ê¼Ò¼¼Æ÷
hypoxic cell sensitizer
Àú»ê¼Ò¼¼Æ÷°¨ÀÛÁ¦
i-cell disease
I-¼¼Æ÷º´
idiotype specific regulatory cell
°³º°Æ¯ÀÌÇü Á¶Àý¼¼Æ÷
immortalized cell
¹«ÇÑÁõ½Ä¼¼Æ÷
immunity,cell-mediated
¼¼Æ÷¸Å°³¼º(á¬øàØÚË¿àõ)
immunocompetent cell
¸é¿ªÀû°Ý¼¼Æ÷.
immunodeficiency syndrome, cell mediated
¼¼Æ÷¸Å°³ ¸é¿ª°áÇÌ ÁõÈıº
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
cell line
¼¼Æ÷°è(á¬øàͧ).
cell line, established
È®¸³¼¼Æ÷ÁÖ
cell loss
¼¼Æ÷¼Ò½Ç
cell loss factor
¼¼Æ÷¼Ò½Ç°è¼ö
cell lysis
¼¼Æ÷¿ëÇØ
cell mass
¼¼Æ÷µ¢¾î¸®, ¼¼Æ÷±«
cell mass
¿ø±â¼¼Æ÷±º(ê«Ðñá¬øàÏØ).
cell matrix
¼¼Æ÷±âÁú
cell maturation
¼¼Æ÷¼º¼÷
cell mediated hypersensitivity
¼¼Æ÷¸Å°³ °ú¹Î¹ÝÀÀ
cell mediated immunity
¼¼Æ÷¼º¸é¿ª.
cell mediated immunity deficiency syndrome
¼¼Æ÷(¸Å°³)¸é¿ª°áÇÌÁõÈıº.
cell mediated immunity deficiency syndrome
¼¼Æ÷¼º¸é¿ª°áÇÌÁõÈıº.
cell mediated lympholysis
¼¼Æ÷¸Å°³ ¸²ÇÁ±¸¿ëÇØ
cell mediated reaction
¼¼Æ÷¸Å°³¼º ¹ÝÀÀ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
18
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½